Hypertension Trials in Oslo, Norway
Conditions / Hypertension / Oslo, Norway
Research into Hypertension spans multiple therapeutic approaches and trial phases.
21 total trials for this combination
Showing top 10 of 21 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00110422 | Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome | COMPLETED | PHASE4 |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT00327912 | Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity | UNKNOWN | PHASE4 |
| NCT00882336 | European Study of Cardiovascular Risk | COMPLETED | — |
| NCT01370005 | 12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT04364126 | Home Blood Pressure Monitoring in Kidney Transplant Recipients | TERMINATED | NA |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING | — |
| NCT01008306 | Cardiovascular Risk Factors After Renal Transplantation in Children and Adults | UNKNOWN | — |
| NCT01412554 | Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up | COMPLETED | — |